Home/Filings/4/0001209191-10-051211
4//SEC Filing

Karlson Elisa A. 4

Accession 0001209191-10-051211

CIK 0000930184other

Filed

Oct 19, 8:00 PM ET

Accepted

Oct 20, 5:52 PM ET

Size

12.2 KB

Accession

0001209191-10-051211

Insider Transaction Report

Form 4
Period: 2010-09-28
Karlson Elisa A.
EVP & Chief Administrative
Transactions
  • Disposition to Issuer

    Common Stock

    2010-09-28218,6630 total
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2010-09-2825,8560 total
    Exercise: $15.47Exp: 2018-05-20Common Stock (25,865 underlying)
  • Disposition to Issuer

    Non-qualified Stock Option (right to buy)

    2010-09-2899,1440 total
    Exercise: $15.47Exp: 2018-05-20Common Stock (99,144 underlying)
  • Disposition to Issuer

    Non-qualified Stock Option (right to buy)

    2010-09-2855,9700 total
    Exercise: $38.47Exp: 2017-03-03Common Stock (55,970 underlying)
Footnotes (3)
  • [F1]8,978 restricted stock units disposed pursuant to merger agreement between issuer and Biovail Corporation, among others, in exchange for 25,119 Valeant Pharmaceuticals International, Inc. (formerly known as Biovail Corporation) restricted stock units, on the same terms and conditions. Remaining 209,685 restricted stock units disposed pursuant to merger agreement between issuer and, among others, Biovail Corporation in exchange for 373,428 shares of Valeant Pharmaceuticals International Inc. common stock. The fair market value of Valeant Pharmaceuticals International, Inc. on the effective date of the merger was $26.00 per share.
  • [F2]This option was assumed by Valeant Pharmaceuticals International, Inc. in the merger and replaced with an option to purchase 349,722 shares of Valeant Pharmaceuticals International, Inc. common stock for $5.53 per share.
  • [F3]This option was assumed by Valeant Pharmaceuticals International, Inc. in the merger and replaced with an option to purchase 156,590 shares of Valeant Pharmaceuticals International, Inc. common stock for $13.75 per share.

Issuer

VALEANT PHARMACEUTICALS INTERNATIONAL

CIK 0000930184

Entity typeother

Related Parties

1
  • filerCIK 0001435755

Filing Metadata

Form type
4
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 5:52 PM ET
Size
12.2 KB